1. Adelsberg J van, Gann P, Ko AT, Damber JE, Logothetis C, Marberger M, Schmitz-Drager BJ, Tubaro A, Harms CJ, Roehrborn C (2007) The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups. Curr Med Res Opin 23(9):2063–2070
2. Allen NE, Roddam AW, Sieri S, Boeing H, Jakobsen MU, Overvad K, Tjønneland A, Halkjaer J, Vineis P, Contiero P, Palli D, Tumino R, Mattiello A, Kaaks R, Rohrmann S, Trichopoulou A, Zilis D, Koumantaki Y, Peeters PH, Bueno-de-Mesquita HB, Barricarte A, Rodríguez L, Dorronsoro M, Sánchez MJ, Chirlaque MD, Esquius L, Manjer J, Wallström P, Ljungberg B, Hallmans G, Bingham S, Khaw KT, Boffetta P, Norat T, Mouw T, Riboli E (2009) A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 125(4):982–987
3. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamine E and beta carotene on the incidence of lung cancers and and other cancers in male smokers. N Engl J Med 300:1029–1035
4. Amaral AF, Cantor KP, Silverman DT, Malats N (2010) Selenium and bladder cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19(9):2407–2415
5. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS, REDUCE Study Group (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362(13):1192–1202